Dr. Michail Panagiotidis

Overview

Summary:

Professional Experience:
01/2025-present: Professor & Department Head
Department of Comparative Biomedical Sciences, College of Veterinary Medicine, Mississippi State University, Mississippi, USA
11/2019-12/2024: Senior Scientist & Department Head
Department of Cancer Genetics, Therapeutics & Ultrastructural Pathology, Cyprus Institute of Neurology & Genetics, Nicosia, CYPRUS
09/2016-10/2019: Professor
Department of Applied Sciences, Faculty of Health & Life Sciences, Northumbria University, Newcastle Upon Tyne, England, UK
01/2013-08/2016: Professor & Chair
School of Life Sciences, Heriot Watt University, Edinburgh, Scotland, UK
01/2012-12/2012: Assistant Professor
Department of Pathological Anatomy, University of Ioannina, Medical School, Ioannina, GREECE
07/2009-06/2011: Adjunct Assistant Professor
School of Community Health Sciences, University of Nevada-Reno, Nevada, USA
07/2007-06/2009: Assistant Professor
School of Community Health Sciences, University of Nevada-Reno, Nevada, USA
08/2006-06/2007: Research Assistant Professor
Department of Nutrition, School of Global Public Health, University of North Carolina-Chapel Hill, North Carolina, USA
07/2004-07/2006: IRTA Postdoctoral Fellow
Laboratory of Signal Transduction, National Institute of Environmental Health Sciences (NIEHS/NIH), North Carolina, USA

Education:

• Doctor of Philosophy, Toxicoloy, University of Colorado-Denver, 2004

Research interests:

Multidisciplinary research in several areas of academic and industrial interests:
A. Cancer therapeutics: Understanding the genetic/epigenetic background in cancer pathophysiology, development of translational cancer therapeutics and the role of phytochemicals in clinical adjuvant therapeutic strategies.
B. One Health Initiative: Environmental contamination, disease emergence / re-emergence and global health, personalised nutrition and chronic disease prevention.
C. Circular economy: health-promoting properties of sustainable and eco-friendly biomolecules for the development of end user applications / consumer product formulations, waste recycling.
D. Biomedical Engineering: Biocompatibility and functional performance of novel engineered materials for orthopaedic implants, drug delivery platforms, etc.